Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Medytox Solutions, Inc. | ex9901.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to
Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 16, 2015
| Medytox Solutions, Inc. |
| (Exact name of registrant as specified in its charter) |
| Nevada | 000-54346 | 90-0902741 | ||
| (State or Other jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
|
400 S. Australian Avenue Suite 800 West Palm Beach, Florida |
33401 | |
| (Address of Principal Executive Offices) | (Zip Code) |
| 561-855-1626 |
| (Registrant’s telephone number, including area code) |
| Not Applicable |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [X] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events
On April 16, 2015, Medytox Solutions, Inc. (the "Company") issued a press release announcing that the Company entered into a definitive merger agreement with CollabRx, Inc. A copy of the press release is filed as Exhibit 99.1 to this report.
ITEM 9.01. Financial Statements and Exhibits
(d) Exhibits
| Exhibit Number | Description |
| 99.1 | Press Release, dated April 16, 2015. |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDYTOX SOLUTIONS, INC. | |
| Dated: April 16, 2015 | /s/ Seamus Lagan |
| Seamus Lagan | |
|
Chief Executive Officer (principal executive officer) |
| 3 |
EXHIBIT INDEX
| Exhibit Number | Description | |
| 99.1 | Press Release, dated April 16, 2015. | |
| 4 |